IL139696A0 - Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies - Google Patents
Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodiesInfo
- Publication number
- IL139696A0 IL139696A0 IL13969699A IL13969699A IL139696A0 IL 139696 A0 IL139696 A0 IL 139696A0 IL 13969699 A IL13969699 A IL 13969699A IL 13969699 A IL13969699 A IL 13969699A IL 139696 A0 IL139696 A0 IL 139696A0
- Authority
- IL
- Israel
- Prior art keywords
- neisseria meningitidis
- antigenic polypeptides
- protective antibodies
- corresponding polynucleotides
- polypeptides
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 241000588650 Neisseria meningitidis Species 0.000 title abstract 2
- 102000040430 polynucleotide Human genes 0.000 title abstract 2
- 108091033319 polynucleotide Proteins 0.000 title abstract 2
- 239000002157 polynucleotide Substances 0.000 title abstract 2
- 230000000890 antigenic effect Effects 0.000 title 1
- 230000001681 protective effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9811260.0A GB9811260D0 (en) | 1998-05-26 | 1998-05-26 | Novel compounds |
| PCT/EP1999/003603 WO1999061620A2 (en) | 1998-05-26 | 1999-05-26 | Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL139696A0 true IL139696A0 (en) | 2002-02-10 |
Family
ID=10832701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13969699A IL139696A0 (en) | 1998-05-26 | 1999-05-26 | Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6994860B1 (pt) |
| EP (1) | EP1080198B1 (pt) |
| JP (1) | JP2002516105A (pt) |
| KR (1) | KR20010052409A (pt) |
| CN (1) | CN1322249A (pt) |
| AT (1) | ATE312921T1 (pt) |
| AU (1) | AU761185B2 (pt) |
| BR (1) | BR9911601A (pt) |
| CA (1) | CA2329269A1 (pt) |
| DE (1) | DE69928925T2 (pt) |
| ES (1) | ES2253893T3 (pt) |
| GB (1) | GB9811260D0 (pt) |
| HU (1) | HUP0102730A2 (pt) |
| IL (1) | IL139696A0 (pt) |
| MX (1) | MXPA00011764A (pt) |
| NO (1) | NO20005952L (pt) |
| NZ (1) | NZ508324A (pt) |
| PL (1) | PL345793A1 (pt) |
| TR (1) | TR200003467T2 (pt) |
| WO (1) | WO1999061620A2 (pt) |
| ZA (1) | ZA200006872B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000050074A2 (en) * | 1999-02-22 | 2000-08-31 | Microbiological Research Authority | Neisserial vaccine compositions and methods |
| US7081244B2 (en) | 1999-02-22 | 2006-07-25 | Health Protection Agency | Neisserial vaccine compositions and methods |
| GB0011108D0 (en) * | 2000-05-08 | 2000-06-28 | Microscience Ltd | Virulence gene and protein and their use |
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| CA2493977A1 (en) | 2002-08-02 | 2004-02-19 | Glaxosmithkline Biologicals Sa | Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| GB0419918D0 (en) * | 2004-09-08 | 2004-10-13 | Imp College Innovations Ltd | Vaccine |
| JP2013521770A (ja) | 2010-03-10 | 2013-06-13 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン組成物 |
| WO2012059592A1 (en) * | 2010-11-05 | 2012-05-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compounds for delivering a therapeutic or imaging agent to the brain |
| US10000545B2 (en) | 2012-07-27 | 2018-06-19 | Institut National De La Sante Et De La Recherche Medicale | CD147 as receptor for pilus-mediated adhesion of Meningococci to vascular endothelia |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4271147A (en) | 1980-01-10 | 1981-06-02 | Behringwerke Aktiengesellschaft | Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same |
| JPH01125328A (ja) * | 1987-07-30 | 1989-05-17 | Centro Natl De Biopreparados | 髄膜炎菌ワクチン |
| FR2751000B1 (fr) | 1996-07-12 | 1998-10-30 | Inst Nat Sante Rech Med | Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques |
-
1998
- 1998-05-26 GB GBGB9811260.0A patent/GB9811260D0/en not_active Ceased
-
1999
- 1999-05-26 IL IL13969699A patent/IL139696A0/xx unknown
- 1999-05-26 AT AT99927754T patent/ATE312921T1/de not_active IP Right Cessation
- 1999-05-26 NZ NZ508324A patent/NZ508324A/en not_active IP Right Cessation
- 1999-05-26 ZA ZA200006872A patent/ZA200006872B/en unknown
- 1999-05-26 MX MXPA00011764A patent/MXPA00011764A/es unknown
- 1999-05-26 CA CA002329269A patent/CA2329269A1/en not_active Abandoned
- 1999-05-26 AU AU45006/99A patent/AU761185B2/en not_active Ceased
- 1999-05-26 CN CN99809103A patent/CN1322249A/zh active Pending
- 1999-05-26 WO PCT/EP1999/003603 patent/WO1999061620A2/en not_active Ceased
- 1999-05-26 EP EP99927754A patent/EP1080198B1/en not_active Expired - Lifetime
- 1999-05-26 JP JP2000551004A patent/JP2002516105A/ja active Pending
- 1999-05-26 US US09/701,271 patent/US6994860B1/en not_active Expired - Fee Related
- 1999-05-26 PL PL99345793A patent/PL345793A1/xx unknown
- 1999-05-26 ES ES99927754T patent/ES2253893T3/es not_active Expired - Lifetime
- 1999-05-26 DE DE69928925T patent/DE69928925T2/de not_active Expired - Lifetime
- 1999-05-26 KR KR1020007013336A patent/KR20010052409A/ko not_active Withdrawn
- 1999-05-26 BR BR9911601-4A patent/BR9911601A/pt not_active IP Right Cessation
- 1999-05-26 HU HU0102730A patent/HUP0102730A2/hu unknown
- 1999-05-26 TR TR2000/03467T patent/TR200003467T2/xx unknown
-
2000
- 2000-11-24 NO NO20005952A patent/NO20005952L/no not_active Application Discontinuation
-
2005
- 2005-08-18 US US11/206,539 patent/US20060189792A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999061620A3 (en) | 2000-03-02 |
| NZ508324A (en) | 2002-07-26 |
| EP1080198A2 (en) | 2001-03-07 |
| ATE312921T1 (de) | 2005-12-15 |
| CA2329269A1 (en) | 1999-12-02 |
| ES2253893T3 (es) | 2006-06-01 |
| US20060189792A1 (en) | 2006-08-24 |
| EP1080198B1 (en) | 2005-12-14 |
| US6994860B1 (en) | 2006-02-07 |
| TR200003467T2 (tr) | 2001-04-20 |
| NO20005952D0 (no) | 2000-11-24 |
| JP2002516105A (ja) | 2002-06-04 |
| BR9911601A (pt) | 2001-02-06 |
| MXPA00011764A (es) | 2003-04-25 |
| ZA200006872B (en) | 2002-01-23 |
| GB9811260D0 (en) | 1998-07-22 |
| PL345793A1 (en) | 2002-01-02 |
| DE69928925D1 (de) | 2006-01-19 |
| WO1999061620A2 (en) | 1999-12-02 |
| AU4500699A (en) | 1999-12-13 |
| CN1322249A (zh) | 2001-11-14 |
| AU761185B2 (en) | 2003-05-29 |
| KR20010052409A (ko) | 2001-06-25 |
| HUP0102730A2 (hu) | 2001-11-28 |
| NO20005952L (no) | 2001-01-18 |
| DE69928925T2 (de) | 2006-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1999058683A3 (en) | BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) | |
| IL139696A0 (en) | Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies | |
| AU5862299A (en) | Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses | |
| WO2000055327A3 (en) | Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies | |
| GB9809683D0 (en) | Novel compounds | |
| WO2000043519A3 (en) | Neisseria meningitidis polypeptides | |
| GB9810285D0 (en) | Novel compounds | |
| WO2000042191A3 (en) | Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies | |
| GB9812440D0 (en) | Novel compounds | |
| GB9812163D0 (en) | Novel compounds | |
| WO2000034482A3 (en) | Novel compounds derived from neisseria meningitidis | |
| GB0025170D0 (en) | Novel compounds | |
| GB9918302D0 (en) | Novel compounds | |
| GB9918003D0 (en) | Novel compounds | |
| HK1042515A1 (zh) | 來自腦膜炎球菌的basb055多核苷酸和多肽，其使用法 | |
| HK1042924A1 (zh) | 從淋球性腦膜炎獲得的basb059多肽 | |
| GB0025169D0 (en) | Novel compounds | |
| WO2002066503A3 (en) | H. influenzae antigen basb213 | |
| ATE293693T1 (de) | Moraxella catarrhalis antigen basb117 | |
| GB9918281D0 (en) | Novel compounds | |
| GB9914945D0 (en) | Novel compounds |